A carregar...
From Biology to Therapy: The CLL Success Story
Chemoimmunotherapy has been the standard of care for patients with chronic lymphocytic leukemia (CLL) over the last decade. Advances in monoclonal antibody technology have resulted in the development of newer generations of anti-CD20 antibodies with improved therapeutic effectiveness. In parallel, o...
Na minha lista:
| Publicado no: | Hemasphere |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6746030/ https://ncbi.nlm.nih.gov/pubmed/31723816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000175 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|